I. INTRODUCTION
The guided bone regeneration (GBR) procedure has been used successfully when there is insufficient bone volume for implant placement [1] [2] [3] . Bone graft materials are used in conjunction with barrier membranes to improve the outcomes of GBR procedures: they stabilize the blood clot, prevent membrane shrinkage and maintain the space available for new bone formation beneath the membrane [4] [5] [6] . Autogenous bone is the preferred augmentation material but harvesting of autogenous bone requires surgery, which is associated with donor site morbidity, a long operation and high costs [7] [8] [9] . A variety of graft materials are used as alternatives to autogenous grafts [10] [11] [12] [13] [14] . Bioactive glass is considered an effective bone graft substitute because of its bone-binding properties 15, 16) . Chemical bonds form between bone tissue and a calcium phosphate layer formed by ion exchange on the surface of bioactive glass [17] [18] [19] [20] [21] .
Many studies have demonstrated that bioactive glass has positive effects on bone healing in human sinus floor elevation and human extraction sockets [22] [23] [24] . 1) Despite the high efficacy of bioactive glass as a grafting material for sinus floor elevation, 22, [24] [25] [26] [27] histological validation of its efficacy for the treatment of horizontal ridge deficiency in conjunction with GBR is limited to a relatively short-term study (6 months) 28) . In our study, we obtained bone biopsies at various times after the operations and evaluated bone healing using histology. We evaluated the effi- 
II. MATERIALS AND METHODS

Patients and surgical procedure
Among the patients who received bone augmentation surgery because of inadequate alveolar ridge widths for implant placement, four systemically healthy nonsmoking patients (2 men and 2 women, 37 to 58 years old) with different healing times were admitted to the study ( Table 1) 
III. RESULTS
Clinical observations
All of the augmented sites healed unevent- 
Histological and histomorphometical results
Histological examination revealed little new bone formation in biopsies harvested from implant sites up to 8 months after the operation (Figures 1 and 2 ). Cracking and fragmentation of BG particles were visible in all specimens.
Most remaining BG particles were encapsulated by connective tissue (Figures 1-3 ). In biopsies harvested at months 6 and 8, there was no evidence of incorporation of new native bone into the graft. Histomorphometry showed that the NB% at months 6 and 8 was 2.5% and 1.9% of the total defect volumes, respectively ( Table   2 ). The mean BG% at months 6 and 8 was Figure 3 ). The mean NB% was 13.2% and the mean BG% was 30.7% (Table 2) In our study, when bioactive glass was used for horizontal ridge augmentation, bone healing was poor compared to that reported in other human studies [22] [23] [24] . Histological analysis re- Many studies suggested that ionic dissolution products and internal excavation of BG particles play key roles in osteoblast differentiation and subsequent bone formation 17, 20, 21, 29) . Several studies suggested that each bioactive glass particle functions as a nucleus for bone growth, thereby enhancing bone healing 17, 20) . While many studies have demonstrated that bioactive glass has beneficial effects on bone healing in vitro, evidence from in vivo trials with humans is conflicting [22] [23] [24] 28, 30) . Tadjoedin et al 24, 31) . reported that bioactive glass particles (Biogran ® , 300-355 ㎛) induced 36% new bone growth at month 6 of healing after sinus floor elevation.
In contrast, Knapp et al 28) . demonstrated that bioactive glass had poor osteoconduction for the treatment of horizontal alveolar ridge defects in conjunction with GBR. After 6 months of healing, the grafted sites showed poor new bone formation (10% or less in 6 of 10 patients) and most residual BG particles exhibited connective tissue encapsulation, which is similar to our findings. Norton and Wilson 30) found no evidence of new bone formation in healing extraction sockets 6 months after the operation and suggested that a longer time may be required for the graft-healing effect to become evident because a small amount of new bone was incorporated into sites with bioactive glass 7 months after the graft.
In our trial, the area occupied by residual BG particles was greater than that reported in other studies 23, 24, 31) . The residual Biogran ® particles accounted for 18.9% of the defect area after 18 months, suggesting that Biogran ® degrades slowly. In contrast, Tadjoedin et al 24, 31) .
reported that residual BG particles accounted for 8% of the defect area at 15 months and were absent at 16 months when combined with a small amount of autogenous bone in sinus floor elevation. Froum et al 23) . reported that residual BG particles occupied 5.5% of the areas of extraction sockets up to month 8 of healing.
Histological differences between studies may be related to differences in healing times, proper- . examined the long-term influence of bone substitutes combined with GBR on bone formation and demonstrated that newly formed bone occupied 12.6% of the area of Biogran ® grafted defects and 88.2% of the area of nongrafted control defects after 1 year. However, it should be noted that conflicting histological results have also been reported for similar types of defects such as human extraction sockets 23, 30) and periodontal osseous defects [39] [40] [41] [42] .
With GBR, other bone substitutes, such as deproteinized bovine bone, induced greater new bone formation than the bioactive glass used in our study. Studies of human alveolar ridge augmentation showed that deproteinized bovine bone induces 17%-27% new bone formation with a considerable degree of direct contact between newly formed bone and the residual graft after 6 months of healing 11, 14, 43) . These differences in bone healing indicate that more human histological studies are needed to confirm the effectiveness of BG in the treatment of osseous defects.
In our study, the increase in the width of the alveolar ridge induced by bioactive glass was sufficient for placement of an implant combined with a titanium reinforced e-PTFE barrier membrane but histological evaluation revealed poor bone healing, even after 18 months.
The limited information obtained from this case series suggests that bioactive glass particles are not suitable for bone regeneration with GBR for treatment of horizontal ridge defects.
